184 related articles for article (PubMed ID: 15492263)
1. Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype.
Haven CJ; Howell VM; Eilers PH; Dunne R; Takahashi M; van Puijenbroek M; Furge K; Kievit J; Tan MH; Fleuren GJ; Robinson BG; Delbridge LW; Philips J; Nelson AE; Krause U; Dralle H; Hoang-Vu C; Gimm O; Morreau H; Marsh DJ; Teh BT
Cancer Res; 2004 Oct; 64(20):7405-11. PubMed ID: 15492263
[TBL] [Abstract][Full Text] [Related]
2. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma.
Shattuck TM; Välimäki S; Obara T; Gaz RD; Clark OH; Shoback D; Wierman ME; Tojo K; Robbins CM; Carpten JD; Farnebo LO; Larsson C; Arnold A
N Engl J Med; 2003 Oct; 349(18):1722-9. PubMed ID: 14585940
[TBL] [Abstract][Full Text] [Related]
3. CDC73/HRPT2 CpG island hypermethylation and mutation of 5'-untranslated sequence are uncommon mechanisms of silencing parafibromin in parathyroid tumors.
Hahn MA; Howell VM; Gill AJ; Clarkson A; Weaire-Buchanan G; Robinson BG; Delbridge L; Gimm O; Schmitt WD; Teh BT; Marsh DJ
Endocr Relat Cancer; 2010 Mar; 17(1):273-82. PubMed ID: 20026646
[TBL] [Abstract][Full Text] [Related]
4. Surveillance for early detection of aggressive parathyroid disease: carcinoma and atypical adenoma in familial isolated hyperparathyroidism associated with a germline HRPT2 mutation.
Kelly TG; Shattuck TM; Reyes-Mugica M; Stewart AF; Simonds WF; Udelsman R; Arnold A; Carpenter TO
J Bone Miner Res; 2006 Oct; 21(10):1666-71. PubMed ID: 16995822
[TBL] [Abstract][Full Text] [Related]
5. Loss of parafibromin expression in a subset of parathyroid adenomas.
Juhlin C; Larsson C; Yakoleva T; Leibiger I; Leibiger B; Alimov A; Weber G; Höög A; Villablanca A
Endocr Relat Cancer; 2006 Jun; 13(2):509-23. PubMed ID: 16728578
[TBL] [Abstract][Full Text] [Related]
6. Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
Gill AJ; Clarkson A; Gimm O; Keil J; Dralle H; Howell VM; Marsh DJ
Am J Surg Pathol; 2006 Sep; 30(9):1140-9. PubMed ID: 16931959
[TBL] [Abstract][Full Text] [Related]
7. Defining a molecular phenotype for benign and malignant parathyroid tumors.
Fernandez-Ranvier GG; Khanafshar E; Tacha D; Wong M; Kebebew E; Duh QY; Clark OH
Cancer; 2009 Jan; 115(2):334-44. PubMed ID: 19107770
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue.
Corbetta S; Vaira V; Guarnieri V; Scillitani A; Eller-Vainicher C; Ferrero S; Vicentini L; Chiodini I; Bisceglia M; Beck-Peccoz P; Bosari S; Spada A
Endocr Relat Cancer; 2010 Mar; 17(1):135-46. PubMed ID: 19926710
[TBL] [Abstract][Full Text] [Related]
9. Different somatic alterations of the HRPT2 gene in a patient with recurrent sporadic primary hyperparathyroidism carrying an HRPT2 germline mutation.
Cetani F; Pardi E; Ambrogini E; Viacava P; Borsari S; Lemmi M; Cianferotti L; Miccoli P; Pinchera A; Arnold A; Marcocci C
Endocr Relat Cancer; 2007 Jun; 14(2):493-9. PubMed ID: 17639062
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of FGFR1 expression is associated with parathyroid carcinogenesis in HPT-JT syndrome due to an HRPT2 splicing mutation.
Lee JY; Kim SY; Mo EY; Kim ES; Han JH; Maeng LS; Lee AH; Eun JW; Nam SW; Moon SD
Int J Oncol; 2014 Aug; 45(2):641-50. PubMed ID: 24889687
[TBL] [Abstract][Full Text] [Related]
11. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
[TBL] [Abstract][Full Text] [Related]
12. Gland size is associated with changes in gene expression profiles in sporadic parathyroid adenomas.
Rosen JE; Costouros NG; Lorang D; Burns AL; Alexander HR; Skarulis MC; Cochran C; Pingpank JF; Marx SJ; Spiegel AM; Libutti SK
Ann Surg Oncol; 2005 May; 12(5):412-6. PubMed ID: 15915376
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid carcinoma.
Mittendorf EA; McHenry CR
J Surg Oncol; 2005 Mar; 89(3):136-42. PubMed ID: 15719375
[TBL] [Abstract][Full Text] [Related]
14. Familial hyperparathyroidism: surgical outcome after 30 years of follow-up in three families with germline HRPT2 mutations.
Sarquis MS; Silveira LG; Pimenta FJ; Dias EP; Teh BT; Friedman E; Gomez RS; Tavares GC; Eng C; De Marco L
Surgery; 2008 May; 143(5):630-40. PubMed ID: 18436011
[TBL] [Abstract][Full Text] [Related]
15. [Hyperparathyroidism-jaw tumor syndrome. A hereditary form of primary hyperparathyroidism with parathyroid carcinoma].
Raue F; Haag Ch; Frank-Raue K
Dtsch Med Wochenschr; 2007 Jul; 132(27):1459-62. PubMed ID: 17583828
[TBL] [Abstract][Full Text] [Related]
16. Parafibromin immunoreactivity: its use as an additional diagnostic marker for parathyroid tumor classification.
Juhlin CC; Villablanca A; Sandelin K; Haglund F; Nordenström J; Forsberg L; Bränström R; Obara T; Arnold A; Larsson C; Höög A
Endocr Relat Cancer; 2007 Jun; 14(2):501-12. PubMed ID: 17639063
[TBL] [Abstract][Full Text] [Related]
17. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors.
Cetani F; Pardi E; Borsari S; Viacava P; Dipollina G; Cianferotti L; Ambrogini E; Gazzerro E; Colussi G; Berti P; Miccoli P; Pinchera A; Marcocci C
J Clin Endocrinol Metab; 2004 Nov; 89(11):5583-91. PubMed ID: 15531515
[TBL] [Abstract][Full Text] [Related]
18. Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma.
Tan MH; Morrison C; Wang P; Yang X; Haven CJ; Zhang C; Zhao P; Tretiakova MS; Korpi-Hyovalti E; Burgess JR; Soo KC; Cheah WK; Cao B; Resau J; Morreau H; Teh BT
Clin Cancer Res; 2004 Oct; 10(19):6629-37. PubMed ID: 15475453
[TBL] [Abstract][Full Text] [Related]
19. [Changes in gene expression in the course of proliferative processes in the parathyroid gland].
Szende B; Arvai K; Peták I; Nagy K; Végsô G; Perner F
Magy Onkol; 2006; 50(2):137-40. PubMed ID: 16888677
[TBL] [Abstract][Full Text] [Related]
20. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression.
Woodard GE; Lin L; Zhang JH; Agarwal SK; Marx SJ; Simonds WF
Oncogene; 2005 Feb; 24(7):1272-6. PubMed ID: 15580289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]